Classification of Breast Cancer Using Neutrosophic Techniques and Deep Neural Network

preprint OA: closed
View at publisher

Abstract

Abstract Breast cancer is one of the most common types of cancer that affects women globally and it is the primary cause of death. Early detection of breast cancer is a vital process that can facilitate appropriate treatment, stop the progression of cancer cells, and reduce morbidity and mortality. Artificial Intelligence (AI) and Machine Learning (ML) are the most popular methods that can be used to detect and classify breast cancer accurately. In this paper, a new strategy for classifying breast cancer using Neutrosophic Techniques (NTs) and machine learning techniques is introduced, which is called Breast Cancer Classification Strategy (BC2S). The proposed BC2S consists of two phases, which are; Data Preprocessing Phase (DP2) and Breast Cancer Classification Phase (BC2P). The main aim of the data preprocessing phase is to; (i) extract features from mammogram images and then remove the outlier items, (ii) select the most effective and informative features from those extracted features using new feature selection method called Efficient Ant Colony Optimization (EACO), and (iii) convert the selected features from classical domain into neutrosophic domain using NTs to give accurate classification through the next classification phase BC2P. The proposed classification model uses Deep Neural Network (DNN) to determine whether the patient is normal or infected with benign or malignant cancer. According to experimental results, the proposed strategy outperforms other competitors in terms of accuracy, precision, recall, and F-measure.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00